Smart nanodevice combined tumor-specific vector with cellular microenvironment-triggered property for highly effective antiglioma therapy

ACS Nano

Volumn 8, Issue 2, 2014, Pages 1191-1203

  Shao, Kun ^a   Ding, Ning ^a   Huang, Shixian ^a   Ren, Sumei ^a   Zhang, Yu ^a   Kuang, Yuyang ^a   Guo, Yubo ^a   Ma, Haojun ^a   An, Sai ^a   Li, Yingxia ^a   Jiang, Chen ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

antiglioma; cellular microenvironment; dehydroascorbic acid; GLUT1; glutathione triggered; polymeric micelles; U87 xenograft model

Indexed keywords

DRUG CARRIER; NANOMATERIAL;

ANIMAL; ARTICLE; BRAIN TUMOR; GLIOMA; HUMAN; MOUSE; TUMOR MICROENVIRONMENT; XENOGRAFT;

ANIMALS; BRAIN NEOPLASMS; DRUG CARRIERS; GLIOMA; HETEROGRAFTS; HUMANS; MICE; NANOSTRUCTURES; TUMOR MICROENVIRONMENT;

EID: 84894625523     PISSN: 19360851     EISSN: 1936086X     Source Type: Journal    
DOI: 10.1021/nn406285x     Document Type: Article

References (56)

1. Brown, M.; Schrot, R.; Bauer, K.; Dodge, J. Incidence of First Primary Central Nervous System Tumors in California, 2001-2005: Children, Adolescents and Teens J. Neurooncol. 2009, 94, 263-273
2. Agarwal, S.; Sane, R.; Oberoi, R.; Ohlfest, J. R.; Elmquist, W. F. Delivery of Molecularly Targeted Therapy to Malignant Glioma, a Disease of the Whole Brain Expert Rev. Mol. Med. 2011, 13, 1-27
3. Pardridge, W. M. The Blood-Brain Barrier: Bottleneck in Brain Drug Development NeuroRx 2005, 2, 3-14
4. Pardridge, W. M. Blood-Brain Barrier Delivery Drug Discovery Today 2007, 12, 54-61
5. Zhan, C.; Lu, W. The Blood-Brain/Tumor Barriers: Challenges and Chances for Malignant Gliomas Targeted Drug Delivery Curr. Pharm. Biotechnol. 2012, 13, 2380-2387
6. Allhenn, D.; Boushehri, M. A.; Lamprecht, A. Drug Delivery Strategies for the Treatment of Malignant Gliomas Int. J. Pharm. 2012, 436, 299-310
7. Gabathuler, R. Approaches To Transport Therapeutic Drugs across the Blood-Brain Barrier To Treat Brain Diseases Neurobiol. Dis. 2010, 37, 48-57
8. Scherrmann, J. M. Drug Delivery to Brain via the Blood-Brain Barrier Vasc. Pharmacol. 2002, 38, 349-354
9. Chen, H.; Zhao, Y.; Wang, H.; Nie, G.; Nan, K. Co-delivery Strategies Based on Multifunctional Nanocarriers for Cancer Therapy Curr. Drug Metab. 2012, 13, 1087-1096
10. Airley, R. E.; Mobasheri, A. Hypoxic Regulation of Glucose Transport, Anaerobic Metabolism and Angiogenesis in Cancer: Novel Pathways and Targets for Anticancer Therapeutics Chemotherapy 2007, 53, 233-256
11. de Boer, A. G.; van der Sandt, I. C.; Gaillard, P. J. The Role of Drug Transporters at the Blood-Brain Barrier Annu. Res. Pharmacol. Toxicol. 2003, 43, 629-656
12. Qin, Y.; Fan, W.; Chen, H.; Yao, N.; Tang, W.; Tang, J.; Yuan, W.; Kuai, R.; Zhang, Z.; Wu, Y. et al. In Vitro and In Vivo Investigation of Glucose-Mediated Brain-Targeting Liposomes J. Drug Target 2010, 18, 536-549
13. Xie, F.; Yao, N.; Qin, Y.; Zhang, Q.; Chen, H.; Yuan, M.; Tang, J.; Li, X.; Fan, W.; Zhang, Q. et al. Investigation of Glucose-Modified Liposomes Using Polyethylene Glycols with Different Chain Lengths as the Linkers for Brain Targeting Int. J. Nanomed. 2012, 7, 163-175
14. Li, J.; Zhou, L.; Ye, D.; Huang, S.; Shao, K.; Huang, R.; Han, L.; Liu, Y.; Liu, S.; Ye, L. et al. Choline-Derivate-Modified Nanoparticles for Brain-Targeting Gene Delivery Adv. Mater. 2011, 23, 4516-4520
15. Jiang, X.; Xin, H.; Ren, Q.; Gu, J.; Zhu, L.; Du, F.; Feng, C.; Xie, Y.; Sha, X.; Fang, X. Nanoparticles of 2-Deoxy-d-Glucose Functionalized Poly(ethylene glycol)-co-Poly(trimethylene carbonate) for Dual-Targeted Drug Delivery in Glioma Treatment Biomaterials 2014, 35, 518-529
16. Wood, I. S.; Trayhurn, P. Glucose Transporters (GLUT and SGLT): Expanded Families of Sugar Transport Proteins Br. J. Nutr. 2003, 89, 3-9
17. Warburg, O. Science 1956, 123, 309-314
18. Vander Heiden, M. G. Targeting Cancer Metabolism: A Therapeutic Window Opens Nat. Rev. Drug Discovery 2011, 10, 671-684
19. Calvaresi, E. C.; Granchi, C.; Tuccinardi, T.; Di Bussolo, V.; Huigens, R. W., III; Lee, H. Y.; Palchaudhuri, R.; Macchia, M.; Martinelli, A.; Minutolo, F. et al. Dual Targeting of the Warburg Effect with a Glucose-Conjugated Lactate Dehydrogenase Inhibitor ChemBioChem 2013, 14, 2263-2267
20. Luo, F.; Liu, X.; Yan, N.; Li, S.; Cao, G.; Cheng, Q.; Xia, Q.; Wang, H. Hypoxia-Inducible Transcription Factor-1α Promotes Hypoxia-Induced A549 Apoptosis via a Mechanism That Involves the Glycolysis Pathway BMC Cancer 2006, 6, 26-35
21. Koff, S. G.; Sterbis, J. R.; Davison, J. M.; Montilla-Soler, J. L. A Unique Presentation of Appendicitis: F-18 FDG PET/CT Clin. Nucl. Med. 2006, 31, 704-706
22. Agus, D. B.; Vera, J. C.; Golde, D. W. Stromal Cell Oxidation: A Mechanism by Which Tumors Obtain Vitamin C Cancer Res. 1999, 59, 4555-4558
23. Rumsey, S. C.; Kwon, O.; Xu, G. W.; Burant, C. F.; Simpson, I.; Levine, M. Glucose Transporter Isoforms GLUT 1 and GLUT 3 Transport Dehydroascorbic Acid J. Biol. Chem. 1997, 272, 18982-18989
24. +-Dependent Vitamin C Transporter but Not Glucose Transporter Pathways J. Biol. Chem. 2005, 280, 5211-5220
25. McCarty, M. F. Expression and/or Activity of the SVCT2 Ascorbate Transporter May Be Decreased in Many Aggressive Cancers, Suggesting Potential Utility for Sodium Bicarbonate and Dehydroascorbic Acid in Cancer Therapy Med. Hypotheses 2013, 81, 664-670
26. Agus, D. B.; Gambhir, S. S.; Pardridge, W. M.; Spielholz, C.; Baselga, J.; Vera, J. C.; Golde, D. W. Vitamin C Crosses the Blood-Brain Barrier in the Oxidized Form through the Glucose Transporters J. Clin. Invest. 1997, 100, 2842-2848
27. Airley, R. E.; Mobasheri, A. Hypoxic Regulation of Glucose Transport, Anaerobic Metabolism and Angiogenesis in Cancer: Novel Pathways and Targets for Anticancer Therapeutics Chemotherapy 2007, 53, 233-256
28. Bourzac, K. Nanotechnology: Carrying Drugs Nature 2012, 491, S58-S60
29. Hemant, S. Overcoming the Challenges in the Effective Delivery of Chemotherapies to CNS Solid Tumors Ther. Delivery 2010, 1, 289-305
30. Wu, G.; Fang, Y. Z.; Yang, S.; Lupton, J. R.; Turner, N. D. Glutathione Metabolism and Its Implications for Health J. Nutr. 2004, 134, 489-492
31. Samarajeewa, S.; Shrestha, R.; Elsabahy, M.; Karwa, A.; Li, A.; Zentay, R. P.; Kostelc, J. G.; Dorshow, R. B.; Wooley, K. L. In Vitro Efficacy of Paclitaxel-Loaded Dual-Responsive Shell Cross-Linked Polymer Nanoparticles Having Orthogonally Degradable Disulfide Cross-Linked Corona and Polyester Core Domains Mol. Pharmacol. 2013, 10, 1092-1099
32. Bae, K. H.; Mok, H.; Park, T. G. Synthesis, Characterization, and Intracellular Delivery of Reducible Heparin Nanogels for Apoptotic Cell Death Biomaterials 2008, 29, 3376-3383
33. Lallana, E.; Fernandez-Trillo, F.; Sousa-Herves, A.; Riguera, R.; Fernandez-Megia, E. Click Chemistry with Polymers, Dendrimers, and Hydrogels for Drug Delivery Pharm. Res. 2012, 29, 902-921
34. Koo, A. N.; Lee, H. J.; Kim, S. E.; Chang, J. H.; Park, C.; Kim, C.; Park, J. H.; Lee, S. C. Disulfide-Cross-Linked PEG-Poly(amino acid)s Copolymer Micelles for Glutathione-Mediated Intracellular Drug Delivery Chem. Commun. 2008, 28, 6570-6572
35. Koo, A. N.; Min, K. H.; Lee, H. J.; Lee, S. U.; Kim, K.; Kwon, I. C.; Cho, S. H.; Jeong, S. Y.; Lee, S. C. Tumor Accumulation and Antitumor Efficacy of Docetaxel-Loaded Core-Shell-Corona Micelles with Shell-Specific Redox-Responsive Cross-Links Biomaterials 2012, 33, 1489-1499
36. Iyer, S. S.; Anderson, A. S.; Reed, S.; Swanson, B.; Schmidt, J. G. Synthesis of Orthogonal End Functionalized Oligoethylene Glycols of Defined Lengths Tetrahedron Lett. 2004, 45, 4285-4288
37. Deming, T. J. Facile Synthesis of Block Copolypeptides of Defined Architecture Nature 1997, 390, 386-389
38. Bach, L. G.; Islam, M. R.; Nga, T. T.; Binh, M. T.; Hong, S. S.; Gal, Y. S.; Lim, K. T. Chemical Modification of Polyhedral Oligomeric Silsesquioxanes by Functional Polymer via Azide-Alkyne Click Reaction J. Nanosci. Nanotechnol. 2013, 13, 1970-1973
39. Gindy, M. E.; Ji, S.; Hoye, T. R.; Panagiotopoulos, A. Z.; Prud'homme, R. K. Preparation of Poly(ethylene glycol) Protected Nanoparticles with Variable Bioconjugate Ligand Density Biomacromolecules 2008, 9, 2705-2711
40. Towner, R. A.; Gillespie, D. L.; Schwager, A.; Saunders, D. G.; Smith, N.; Njoku, C. E.; Krysiak, R. S.; Larabee, C.; Iqbal, H.; Floyd, R. A. et al. Regression of Glioma Tumor Growth in F98 and U87 Rat Glioma Models by the Nitrone OKN-007 Neuro. Oncol. 2013, 15, 330-340
41. Ke, W.; Shao, K.; Huang, R.; Han, L.; Liu, Y.; Li, J.; Kuang, Y.; Ye, L.; Lou, J.; Jiang, C. Gene Delivery Targeted to the Brain Using an Angiopep-Conjugated Polyethyleneglycol-Modified Polyamidoamine Dendrimer Biomaterials 2009, 30, 6976-6985
42. Bottsford-Miller, J. N.; Coleman, R. L.; Sood, A. K. Resistance and Escape from Antiangiogenesis Therapy: Clinical Implications and Future Strategies J. Clin. Oncol. 2012, 30, 4026-4034
43. Yang, L.; Lin, C.; Wang, L.; Guo, H.; Wang, X. Hypoxia and Hypoxia-Inducible Factors in Glioblastoma Multiforme Progression and Therapeutic Implications Exp. Cell Res. 2012, 318, 2417-2426
44. Shimanishi, M.; Ogi, K.; Sogabe, Y.; Kaneko, T.; Dehari, H.; Miyazaki, A.; Hiratsuka, H. Silencing of GLUT-1 Inhibits Sensitization of Oral Cancer Cells to Cisplatin during Hypoxia J. Oral Pathol. Med. 2013, 42, 382-388
45. Lalatsa, A.; Schätzlein, A. G.; Mazza, M.; Le, T. B.; Uchegbu, I. F. Amphiphilic Poly(l-amino acids): New Materials for Drug Delivery J. Controlled Release 2012, 161, 523-536
46. Vivero-Escoto, J. L.; Taylor-Pashow, K. M.; Huxford, R. C.; Della, R. J.; Okoruwa, C.; An, H.; Lin, W.; Lin, W. Multifunctional Mesoporous Silica Sanospheres with Cleavable Gd(III) Chelates as MRI Contrast Agents: Synthesis, Characterization, Target-Specificity, and Renal Clearance Small 2011, 7, 3519-3528
47. Zhan, C. Y.; Wei, X.; Qian, J.; Feng, L.; Zhu, J.; Lu, W. Co-delivery of TRAIL Gene Enhances the Anti-glioblastoma Effect of Paclitaxel in Vitro and in Vivo J. Controlled Release 2012, 160, 630-636
48. Tao, Y.; Ning, M.; Dou, H. A Novel Therapeutic System for Malignant Glioma: Nanoformulation, Pharmacokinetic, and Anticancer Properties of Cell-Nano-Drug Delivery Nanomedicine 2013, 9, 222-232
49. Yoshizawa, Y.; Kono, Y.; Ogawara, K.; Kimura, T.; Higaki, K. PEG Liposomalization of Paclitaxel Improved Its In Vivo Disposition and Anti-tumor Efficacy Int. J. Pharm. 2011, 412, 132-141
50. Abou El Hassan, M. A.; Braam, S. R.; Kruyt, F. A. Paclitaxel and Vincristine Potentiate Adenoviral Oncolysis That Is Associated with Cell Cycle and Apoptosis Modulation, Whereas They Differentially Affect the Viral Life Cycle in Non-Small-Cell Lung Cancer Cells Cancer Gene Ther. 2006, 13, 1105-1114
51. Lee, J. H.; Na, K.; Song, S. C.; Lee, J.; Kuh, H. J. The Distribution and Retention of Paclitaxel and Doxorubicin in Multicellular Layer Cultures Oncol. Rep. 2012, 27, 995-1002
52. Schutters, K.; Reutelingsperger, C. Phosphatidylserine Targeting for Diagnosis and Treatment of Human Diseases Apoptosis 2010, 15, 1072-1082
53. Huang, S.; Shao, K.; Liu, Y.; Kuang, Y.; Li, J.; An, S.; Guo, Y.; Ma, H.; Jiang, C. Tumor-Targeting and Microenvironment-Responsive Smart Nanoparticles for Combination Therapy of Antiangiogenesis and Apoptosis ACS Nano 2013, 7, 2860-2871
54. Gu, G.; Gao, X.; Hu, Q.; Kang, T.; Liu, Z.; Jiang, M.; Miao, D.; Song, Q.; Yao, L.; Tu, Y. et al. The Influence of the Penetrating Peptide iRGD on the Effect of Paclitaxel-Loaded MT1-AF7p-Conjugated Nanoparticles on Glioma Cells Biomaterials 2013, 34, 5138-5148
55. Daly, W. H.; Poche, D. The Preparation of N-Carboxyanhydrides of α-Amino Acids Using Bis(trichloromethyl)carbonate Tetrahedron Lett. 1988, 29, 5859-5862
56. Marra, A.; Vecchi, A.; Chiappe, C.; Melai, B.; Dondoni, A. Validation of the Copper(I)-Catalyzed Azide-Alkyne Coupling in Ionic Liquids. Synthesis of a Triazole-Linked C-Disaccharide as a Case Study J. Org. Chem. 2008, 73, 2458-2461